Hello! My mum has been newly diagnosed as having ALK positive lung cancer, with brain mets. The NHS oncologist we are seeing wants to prescribe Crizotinib but I have been reading that Alectinib is now the new standard for first line treatment. Any thoughts on this would be much appreciated - is it the case that Crizotinib is still okay? If we start on Crizotinib, does this mean that we cannot try Alectinib? I only ask because the NICE guidance seems to indicate that Alectinib can only be used for first line treatment.
Thanks in advance for your help!
My dad was diagnosed in June 2018. Crizotinib does not cross blood/brain barrier and so should definitely not be used if brain mets have been discovered as it won’t work on them. I would push for the Alectinib. My dad started on crizotinib and then brain mets were discovered so he swapped to ceritinib but that didn’t work so he’s now on lorlatinib since beginning of September and is doing really well so far, just had first since starting yday so just waiting on his results now.
Hi Hanl, thanks for your reply and for the information - it is really helpful. Wishing your dad all of the best and really pleased to hear that the Lorlatinib is working for him. Long may it continue!